mannuronic acid has been researched along with Myelodysplastic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghazadeh, Z; Aslani, M; Bakhtiari, T; Cuzzocrea, S; Ghaderi, A; Matsuo, H; Mirshafiey, A; Nodehi, SRS; Rehm, BHA | 1 |
| Aghazadeh, Z; Bakhtiari, T; Barati, A; Ghaderi, A; Jafarnezhad-Ansariha, F; Mirshafiey, A; Safaee Nodehi, SR; Tofighi Zavareh, F | 1 |
1 trial(s) available for mannuronic acid and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Mannuronic Acid in Low-Risk and Intermediate-1-Risk Myelodysplastic Syndromes.
Topics: Administration, Oral; Erythrocyte Transfusion; Female; Folic Acid; Hemoglobins; Hexuronic Acids; Humans; Iatrogenic Disease; Immunosuppressive Agents; Infections; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Treatment Outcome; Vitamin B 12 | 2020 |
1 other study(ies) available for mannuronic acid and Myelodysplastic Syndromes
| Article | Year |
|---|---|
An in vitro assessment for evaluating the efficiency of β-d-mannuronic acid (M2000) in myelodysplastic syndrome.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Female; Gene Expression; Hexuronic Acids; Humans; Immunosuppressive Agents; Interleukin-6; Leukocytes, Mononuclear; Male; Middle Aged; Myelodysplastic Syndromes; Tumor Necrosis Factor-alpha | 2019 |